"The most common primary malignancy types were prostate (n = 14), colorectal (n = 10), lung (n = 7), and breast cancers (n = 6). The median follow-up was 30 months, ranging from 9 to 79. The 1-, 3-, and 5-year PFS and OS rates were 54.9%, 37.0%, and 37.0% and 98.3%, 84.4%, and 73.8%, respectively, and the median time to first progression was 15 (range, 2-32) months. Twenty-four (40%) patients had no recurrence. In our analysis, primary tumor site was not an independent prognostic factor. "
Stereotactic Ablative Radiotherapy in... - Advanced Prostate...
Stereotactic Ablative Radiotherapy in Oligometastatic Disease, new retrospectice study
interesting study, but only 3 prostate cancer patients, and authors note results may be worse with a larger PC population.
thought they were 14??
Sorry, it did say 14 patients. Not sure where I got 3, but here is what it said about the 14. Hopefully there are more studies that can validate the 100% survival rate for men with only bone metastasis. Thank you for sharing the article. I found it hopeful.
“In addition, we analyzed the relationship between the primary tumor site and OS/PFS (Figs 2 and 3). There was no correlation observed in a pairwise comparison of all primary tumor sites (the P value was >.05). The smaller number of patients in our cohort might also have influenced this outcome. We have noted some differences in OS in patients with prostate cancer (P = .073), which had a 100% OS rate. We suppose that this is primarily because the prostate cancers in our study had only bone metastases because of early detection of metastases. We assume that if we had more patients with prostate cancer with metastases to other sites, the OS rates would be worse.”
Title: Stereotactic Ablative Radiotherapy in Oligometastatic Disease, new retrospectice study.
I started whispering this title to my blow up doll and she winked at me. What the hell do you think she means/wants?
Good Luck, Good Health and Good Humor.
j-o-h-n